Molecule Details
| InChIKey | NRQJYHJWUHJYHG-UHFFFAOYSA-N |
|---|---|
| Compound Name | N-naphthalen-2-yl-N-[1-[2-(4-sulfamoylphenyl)ethyl]piperidin-4-yl]propanamide |
| Canonical SMILES | CCC(=O)N(c1ccc2ccccc2c1)C1CCN(CCc2ccc(S(N)(=O)=O)cc2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 8 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.86 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (8)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P43166 | CA7 | Homo sapiens | Human | PF00194 | 7.4 | Ki | ChEMBL |
| O43570 | CA12 | Homo sapiens | Human | PF00194 | 7.4 | Ki | ChEMBL |
| Q9ULX7 | CA14 | Homo sapiens | Human | PF00194 | 7.0 | Ki | ChEMBL |
| P00915 | CA1 | Homo sapiens | Human | PF00194 | 7.0 | Ki | ChEMBL |
| P00918 | CA2 | Homo sapiens | Human | PF00194 | 6.8 | Ki | ChEMBL |
| Q16790 | CA9 | Homo sapiens | Human | PF00194 | 6.8 | Ki | ChEMBL |
| P35218 | CA5A | Homo sapiens | Human | PF00194 | 6.3 | Ki | ChEMBL |
| Q8N1Q1 | CA13 | Homo sapiens | Human | PF00194 | 6.0 | Ki | ChEMBL |